Wild-type p53 gene increases MDR1 gene expression but decreases drug resistance in an MDR cell line KBV200

被引:23
|
作者
Li, ZH
Zhu, YJ
Lit, XT
机构
[1] CHINESE ACAD MED SCI, INST CANC, DEPT PHARMACOL, BEIJING 100021, PEOPLES R CHINA
[2] BEIJING UNION MED COLL, BEIJING 100021, PEOPLES R CHINA
[3] CHINESE ACAD MED SCI, INST CANC, DEPT BIOCHEM, BEIJING 100021, PEOPLES R CHINA
基金
中国国家自然科学基金;
关键词
p53; gene; MDR1; drug resistance; anticancer drug; apoptosis;
D O I
10.1016/S0304-3835(97)00267-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inactivation of p53 gene and overexpression of MDR1 gene are both associated with drug resistance, Previous studies have suggested that p53 gene can modulate the expression activity of MDR1 gene promoter in a promoter-CAT system. In the present study, wild-type p53 gene cDNA was introduced into a multidrug-resistant cell line, KBV200, in which endogenous p53 gene is aberrant. In wt-p53 transfected cells, the expression of MDR1 gene was significantly increased, accumulation of adriamycin (ADM) was decreased, and the sensitivity to vincristine (VCR), ADM and 5-fluorouracil (5-FU) was increased compared with the parent KBV200 cells, After treatment with ADM and VCR, the p53-transfectants were more susceptible to apoptosis. The results suggest that the increase in drug sensitivity of the cells may be, at least in part, due to p53-dependent apoptosis induced by anticancer agents. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 50 条
  • [21] Multidrug resistance 1 gene (MDR1) expression in gingival fibroblasts
    Reynolds, MA
    Hebert, C
    Norris, K
    Sauk, JJ
    JOURNAL OF DENTAL RESEARCH, 1998, 77 : 184 - 184
  • [23] Targeted gene disruption in Candida albicans wild-type strains:: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates
    Wirsching, S
    Michel, S
    Morschhäuser, J
    MOLECULAR MICROBIOLOGY, 2000, 36 (04) : 856 - 865
  • [24] mdm2 Gene mediates the expression of mdr1 gene and P-glycoprotein in a human glioblastoma cell line
    Kondo, S
    Kondo, Y
    Hara, H
    Kaakaji, R
    Peterson, JW
    Morimura, T
    Takeuchi, J
    Barnett, GH
    BRITISH JOURNAL OF CANCER, 1996, 74 (08) : 1263 - 1268
  • [25] MDR1 expression correlates with mutant p53 expression in colorectal cancer metastases
    deKant, E
    Heide, I
    Thiede, C
    Herrmann, R
    Rochlitz, CF
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1996, 122 (11) : 671 - 675
  • [26] Expression of MDR1 and mutant p53 protein in hepatocellular carcinoma.
    Grude, P
    Conti, F
    Louvel, A
    Lecureur, V
    Fardel, O
    Calmus, Y
    HEPATOLOGY, 1997, 26 (04) : 1314 - 1314
  • [27] p53 protein expression in laryngeal squamous cell carcinomas bearing wild-type and mutated p53 gene
    Pruneri, G
    Pignataro, L
    Fracchiolla, NS
    Ferrero, S
    Capaccio, P
    Carboni, N
    Ottaviani, A
    Maiolo, AT
    Neri, A
    Buffa, R
    HISTOPATHOLOGY, 1996, 28 (06) : 513 - 519
  • [28] Conferring drug resistance by MDR1 gene transfection increases susceptibility to irradiation and lipid peroxidation in 3T3 cell line
    Mazzanti, R
    Fantappie, O
    Fabrizio, P
    Pacini, S
    Relli, P
    Casamassima, F
    Milano, F
    Ruggiero, M
    FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (04) : 601 - 606
  • [29] MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models
    Mahon, FX
    Belloc, F
    Lagarde, V
    Chollet, C
    Moreau-Gaudry, F
    Reiffers, J
    Goldman, JM
    Melo, JV
    BLOOD, 2003, 101 (06) : 2368 - 2373